LONDON, Dec 30: Regulators in Asia are weighing approval for COVID-19 vaccines developed by Pfizer Inc with partner BioNTech SE, Moderna Inc and AstraZeneca Plc, but few nations expect to get significant supplies initially.

KATHMANDU, Dec 30: The Ministry of Health and Population (MoHP) has directed all the COVID-19 designated hospitals and authorities concerned to keep record of current address of people visiting them to  provide their swab samples for COVID-19 test.

LONDON, Dec 30: A new variant of the novel coronavirus does not appear to cause more severe illness than other variants, according to a matched study by Public Health England.

Britain first to approve AstraZeneca/Oxford COVID-19 vaccine

Published On: December 30, 2020 02:16 PM NPT By: Reuters

LONDON, Dec 30: Britain on Wednesday became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca as it battles a major winter surge driven by a new, highly contagious variant of the virus.

1st reported US case of COVID-19 variant found in Colorado

Published On: December 30, 2020 12:00 PM NPT By: Associated Press

DENVER, Dec 30: The first reported U.S. case of the COVID-19 variant that’s been seen in the United Kingdom has been discovered in Colorado, Gov. Jared Polis announced Tuesday, adding urgency to efforts to vaccinate Americans.

KATHMANDU, December 29: COVID-19 is taking a serious toll on the earnings of an average Nepali and has heightened the risk of falling into the poverty trap, a national survey showed. It also showed that the government assistance and social security allowance to the affected has declined from August to October 2020.

LONDON, Dec 29: Britain must vaccinate two million people a week to avoid a third wave of the coronavirus outbreak, a study by the London School of Hygiene and Tropical Medicine (LSHTM) has concluded.

6,427 corona patients yet to recover

Published On: December 28, 2020 07:32 PM NPT By: Republica

KATHMANDU, Dec 28: As many 2.5 percent of the total diagnosed patients of the novel coronavirus disease (COVID-19) in Nepal are yet to recover from the disease. This equals to 6,427 patients across the country who are receiving treatment for the flu-like disease either being isolated at their homes or at institutional isolation centers.

LONDON, Dec 28: The head of drugmaker AstraZeneca, which is developing a coronavirus vaccine widely expected to be approved by U.K. authorities this week, said Sunday that researchers believe the shot will be effective against a new variant of the virus driving a rapid surge in infections in Britain.

Of the 77 districts in the country, only Mugu and Rukum (West) have reported zero cases of the flu-like disease, according to the daily COVID-19 bulletin released by the Ministry of Health and Population (MoHP).